To include your compound in the COVID-19 Resource Center, submit it here.
Mouse studies suggest dual inhibition of MCL1 and MEK could help treat KRAS-mutant adenocarcinoma. In seven
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury